FR2436601A1 - Implant de delivrance de medicament pouvant etre enleve - Google Patents

Implant de delivrance de medicament pouvant etre enleve

Info

Publication number
FR2436601A1
FR2436601A1 FR7923357A FR7923357A FR2436601A1 FR 2436601 A1 FR2436601 A1 FR 2436601A1 FR 7923357 A FR7923357 A FR 7923357A FR 7923357 A FR7923357 A FR 7923357A FR 2436601 A1 FR2436601 A1 FR 2436601A1
Authority
FR
France
Prior art keywords
implant
oestradiol
medicine
delivery
biocompatible
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7923357A
Other languages
English (en)
Other versions
FR2436601B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of FR2436601A1 publication Critical patent/FR2436601A1/fr
Application granted granted Critical
Publication of FR2436601B1 publication Critical patent/FR2436601B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'INVENTION CONCERNE UN IMPLANT COMPORTANT UN NOYAU BIOCOMPATIBLE INERTE AYANT UN REVETEMENT CONTENANT ENTRE ENVIRON5 ET ENVIRON 40 D'OESTRADIOL DANS UN CAOUTCHOUC BIOCOMPATIBLE DE DIMETHYLPOLYSILOXANE. QUAND L'IMPLANT EST PLACE SOUS LA PEAU D'UN RUMINANT, L'OESTRADIOL EST LIBERE A UNE VITESSE RELATIVEMENT CONSTANTE EN DONNANT UN GAIN DE POIDS SUPERIEUR A LA NORMALE CHEZ L'ANIMAL. L'IMPLANT RESTE INTACT ET PEUT ETRE ENLEVE DE L'ANIMAL A LA FIN DE LA PERIODE DESIREE DE L'ADMINISTRATION DU MEDICAMENT.
FR7923357A 1978-09-22 1979-09-19 Implant de delivrance de medicament pouvant etre enleve Granted FR2436601A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/944,946 US4191741A (en) 1978-09-22 1978-09-22 Removable drug implant

Publications (2)

Publication Number Publication Date
FR2436601A1 true FR2436601A1 (fr) 1980-04-18
FR2436601B1 FR2436601B1 (fr) 1984-06-08

Family

ID=25482344

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7923357A Granted FR2436601A1 (fr) 1978-09-22 1979-09-19 Implant de delivrance de medicament pouvant etre enleve

Country Status (17)

Country Link
US (1) US4191741A (fr)
EP (1) EP0009410B1 (fr)
JP (1) JPS5545694A (fr)
AU (1) AU531797B2 (fr)
BE (1) BE878883A (fr)
CA (1) CA1128861A (fr)
DE (1) DE2965857D1 (fr)
DK (1) DK155865C (fr)
FR (1) FR2436601A1 (fr)
GB (1) GB2030044B (fr)
HK (1) HK42887A (fr)
IE (1) IE48555B1 (fr)
IL (1) IL58303A (fr)
LU (1) LU81705A1 (fr)
MY (1) MY8500567A (fr)
NZ (1) NZ191587A (fr)
ZA (1) ZA794968B (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4326523A (en) * 1980-08-25 1982-04-27 International Minerals & Chemical Corp. Method of supplying micronutrients to animals
DK119884A (da) * 1983-03-18 1984-09-19 Lilly Co Eli Fast, cylindrisk, subkutan implantation og dens anvendelse
US5385738A (en) * 1983-10-14 1995-01-31 Sumitomo Pharmaceuticals Company, Ltd. Sustained-release injection
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
NZ217844A (en) * 1985-10-11 1989-10-27 Sumitomo Pharma A sustained release pharmaceutical composition containing silicone elastomer and an albumin
US4917685A (en) * 1986-05-16 1990-04-17 International Minerals & Chem. Corp. Delivery device for the administration of stabilized growth promoting hormones
IE58536B1 (en) * 1986-06-09 1993-10-06 Chanelle Chemicals Ltd Subcutaneous implant
FR2602423B1 (fr) * 1986-08-08 1989-05-05 Ethypharm Sa Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede
US4758435A (en) * 1986-08-11 1988-07-19 American Cyanamid Company Estradiol implant composition and method for preparation
GB8704755D0 (en) * 1987-02-28 1987-04-01 Dow Corning Ltd Pharmaceutical delivery device
HU197519B (en) * 1987-06-22 1989-04-28 Biogal Gyogyszergyar Process for producing medicine form capable for penetrating through epidermis and suitable for intaking the agent through epidermis by kinetics of zero-grade
US4846844A (en) * 1987-08-31 1989-07-11 Eli Lilly And Company Antimicrobial coated implants
US5141748A (en) * 1989-02-17 1992-08-25 Hoffmann-La Roche, Inc. Implant drug delivery device
JP3720386B2 (ja) * 1993-12-27 2005-11-24 住友製薬株式会社 薬物放出制御製剤
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
US6197815B1 (en) 1998-03-18 2001-03-06 J.H. Biotech, Inc. Amino acid chelates to reduce still births and increase birth weight in non-human animals
TW586944B (en) 1998-05-29 2004-05-11 Sumitomo Pharma Controlled release agent having a multi-layer structure
US6117441A (en) * 1998-07-02 2000-09-12 The Population Council, Inc. Silicone core long term androgen delivery implant
JP4753471B2 (ja) 1998-09-10 2011-08-24 大日本住友製薬株式会社 長期薬物徐放性製剤
US7767708B2 (en) * 1998-11-04 2010-08-03 Schering-Plough Animal Health Corp. Growth stimulant compositions
US6361780B1 (en) 1998-11-12 2002-03-26 Cardiac Pacemakers, Inc. Microporous drug delivery system
TW524696B (en) * 1999-11-10 2003-03-21 Sumitomo Pharma Sustained-release drug formulations
US7187980B2 (en) * 2001-11-09 2007-03-06 Oscor Inc. Cardiac lead with steroid eluting ring
US20050079132A1 (en) * 2003-04-08 2005-04-14 Xingwu Wang Medical device with low magnetic susceptibility
US20050025797A1 (en) * 2003-04-08 2005-02-03 Xingwu Wang Medical device with low magnetic susceptibility
US20060034943A1 (en) * 2003-10-31 2006-02-16 Technology Innovations Llc Process for treating a biological organism
EP2288335A1 (fr) * 2008-03-28 2011-03-02 Boehringer Ingelheim International GmbH Procédé pour préparer des formulations de dabigatran administrées par voie orale
TWI436994B (zh) 2008-07-14 2014-05-11 Boehringer Ingelheim Int 製備含有達比加群（ｄａｂｉｇａｔｒａｎ）之藥物組合物的新穎方法
US8419793B2 (en) * 2008-09-19 2013-04-16 Mentor Worldwide Llc Coating with antimicrobial agents
US8420153B2 (en) * 2008-09-19 2013-04-16 Mentor Worldwide Llc Coating with antimicrobial agents
AU2009315729A1 (en) 2008-11-11 2010-05-20 Boehringer Ingelheim International Gmbh Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved safety profile over conventional warfarin therapy
SG10201501964QA (en) * 2010-03-16 2015-05-28 Titan Pharmaceuticals Inc Heterogeneous Implantable Devices For Drug Delivery
CN103140226B (zh) 2010-08-06 2015-07-08 大日本住友制药株式会社 用于治疗脊髓损伤的制剂
CN103124565A (zh) 2010-08-06 2013-05-29 大日本住友制药株式会社 用于控制水溶性药物释放的药物制剂
WO2013036775A1 (fr) * 2011-09-09 2013-03-14 Axxia Pharmaceuticals, Llc Implants revêtus de silicone
LT4037666T (lt) 2020-12-08 2024-06-10 Ruminant Biotech Corp Limited Medžiagų pristatymo gyvūnams prietaisų ir būdų patobulinimai

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1366796A (en) * 1971-12-09 1974-09-11 Upjohn Co Medicated devices
US4096239A (en) * 1975-04-28 1978-06-20 Syntex Corporation Inert core implant pellet

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3279996A (en) * 1962-08-28 1966-10-18 Jr David M Long Polysiloxane carrier for controlled release of drugs and other agents
US3499445A (en) * 1966-08-16 1970-03-10 Phytogen Prod Inc Animal husbandry
USRE28536E (en) 1966-08-16 1975-09-02 Animal husbandry
US3545439A (en) * 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
US3920805A (en) * 1971-12-09 1975-11-18 Upjohn Co Pharmaceutical devices and method
DE2445971A1 (de) * 1974-09-24 1976-04-08 Schering Ag Arzneimittelwirkstofftraeger ii
IL48277A (en) * 1974-10-18 1978-03-10 Schering Ag Vaginal ring
US3946106A (en) * 1974-10-24 1976-03-23 G. D. Searle & Co. Microsealed pharmaceutical delivery device
US3992518A (en) * 1974-10-24 1976-11-16 G. D. Searle & Co. Method for making a microsealed delivery device
US4053580A (en) * 1975-01-01 1977-10-11 G. D. Searle & Co. Microsealed pharmaceutical delivery device

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1366796A (en) * 1971-12-09 1974-09-11 Upjohn Co Medicated devices
US4096239A (en) * 1975-04-28 1978-06-20 Syntex Corporation Inert core implant pellet

Also Published As

Publication number Publication date
EP0009410A2 (fr) 1980-04-02
GB2030044B (en) 1983-08-24
FR2436601B1 (fr) 1984-06-08
LU81705A1 (fr) 1980-01-24
IL58303A (en) 1982-03-31
US4191741A (en) 1980-03-04
IL58303A0 (en) 1979-12-30
CA1128861A (fr) 1982-08-03
EP0009410A3 (en) 1980-04-16
HK42887A (en) 1987-06-05
IE48555B1 (en) 1985-03-06
DK155865C (da) 1989-11-13
GB2030044A (en) 1980-04-02
EP0009410B1 (fr) 1983-07-13
IE791791L (en) 1980-03-22
ZA794968B (en) 1981-05-27
DE2965857D1 (en) 1983-08-18
BE878883A (fr) 1980-03-20
DK155865B (da) 1989-05-29
MY8500567A (en) 1985-12-31
JPS5545694A (en) 1980-03-31
DK396279A (da) 1980-03-23
AU531797B2 (en) 1983-09-08
AU5089879A (en) 1980-03-27
NZ191587A (en) 1981-10-19

Similar Documents

Publication Publication Date Title
FR2436601A1 (fr) Implant de delivrance de medicament pouvant etre enleve
CS9004859A2 (en) Method of adhesive plaster production that contains oestrogen as active substance
Stitt et al. The effect of certain progestins and estrogens on the threshold of electrically induced seizure patterns
KR880003617A (ko) 경구용 고형제형과 그의 제조방법
ATE66809T1 (de) Vorrichtung zur arzneistoffabgabe und verfahren zu ihrer herstellung.
IL84167A (en) Oral delivery of bioactive agents to and through the peyer's patch by use of microencapsulation
GR3025362T3 (en) Sol-controlled gelatine-based thermocolloidal matrix for peroral prolonged action administration forms.
HK1038310A1 (en) Compositions and methods for treating intracellular infections.
EP1002538A3 (fr) Stockage de cellules souches et lymphocytes
EP0236002A3 (en) Pharmaceutical composition comprising a medicament and a water-swellable polymer
NZ331051A (en) Instant release forms of gelled active substances
RU2180556C2 (ru) Гель-смазка (варианты)
Chvapil et al. Collagen sponge in gynecologic use
AU610136B2 (en) Preparation for treatment of skin disorders
US2943021A (en) Method for retaining immediate dentures
Ringsdorf Jr et al. Ascorbic acid and glaucoma: a review
Wong et al. Retinal degeneration in dogs following oral administration of an inhibitor of mediator release from IGE sensitized mast cells
Yanagisawa et al. The effect of a substance P antagonist on the capsaicin-induced nociceptive reflex in the isolated spinal cord-tail preparation of the neonatal rat
Chiba et al. Time course of capsaicin effects on dorsal root ganglion neurons of the adult rat: Immunohistochemical and ultrastructural studies
RU95110493A (ru) Средство для лечения кожных заболеваний
Mathur et al. Epidermolysis Bullosa Hereditaria
TH26709A (th) การปล่อยออกเรื่อย ๆ ของเป็ปไทด์จากส่วนประกอบของยา
FR2515044A1 (fr) Composition medicale pour controler le rythme biologique diurne et nocturne de l'organisme humain et plus specifiquement pour combattre les troubles sexuels de l'etre humain